Self reproted physical activity in the dialysis population

透析人群的自我报告体力活动

基本信息

  • 批准号:
    7753523
  • 负责人:
  • 金额:
    $ 6.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-28 至 2012-09-27
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The proposed research on "Self reported physical activity in dialysis patient" supplies information about physical activity from the largest cohort of dialysis patients to date. Physical activity has been to shown to decrease cardiovascular morbidity and mortality in the general population. Cardiovascular disease causes more than 50 percent of the deaths within the end stage renal disease population. Therefore it is important to describe and to understand some of the barriers to physical activity within this population. Our proposed study uses data that have already been collected from a survey of over 1600 patients just beginning dialysis. We plan to describe their level of physical activity from a questionnaire. This questionnaire has been used for many years in describing physical activity among persons with diseases such as heart disease and arthritis. Our proposed study will allow us to compare levels of physical activity for persons on dialysis to persons with other chronic diseases, and to understand which characteristics are associated with higher and lower levels of activity. While patients getting dialysis, particularly hemodialysis, could feasibly participate in an exercise program while at a dialysis center, no formal guidelines for exercise programs have been implemented. An analysis examining the correlation between physical activity, and survival and cause specific hospitalization is needed to motivate such interventions. We will analyze whether a higher level of activity increases the lifespan or decreases the number of hospitalizations for people on dialysis, which in turn will help supply more information about whether physical activity is beneficial for them.
描述(由申请人提供):关于“透析患者自我报告的身体活动”的拟议研究提供了迄今为止最大透析患者队列的身体活动信息。体育活动已被证明可以降低一般人群的心血管发病率和死亡率。在终末期肾病人群中,心血管疾病导致超过50%的死亡。因此,重要的是要描述和了解这一人群中的一些身体活动的障碍。我们提出的研究使用的数据已经从超过1600名刚开始透析的患者的调查中收集。我们计划通过问卷调查来描述他们的身体活动水平。多年来,该问卷一直用于描述患有心脏病和关节炎等疾病的人的身体活动。我们拟议的研究将使我们能够比较透析患者与其他慢性疾病患者的身体活动水平,并了解哪些特征与较高和较低的活动水平相关。 虽然接受透析,特别是血液透析的患者在透析中心可以可行地参与锻炼计划,但尚未实施锻炼计划的正式指南。需要分析身体活动与生存率和特定原因住院之间的相关性,以激励此类干预措施。我们将分析更高水平的活动是否会增加透析患者的寿命或减少其住院次数,这反过来将有助于提供更多关于体力活动是否对他们有益的信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shuchi Anand其他文献

Shuchi Anand的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shuchi Anand', 18)}}的其他基金

Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocation
美国服务不足人群的流行病防范:利用 RADx-UP 联盟的数据评估用于资源分配的公共卫生工具
  • 批准号:
    10881319
  • 财政年份:
    2023
  • 资助金额:
    $ 6.61万
  • 项目类别:
SARS-COV-2 Screening in Dialysis Facilities: Building an Optimal Strategy to Protect High Risk Populations
透析设施中的 SARS-COV-2 筛查:制定保护高危人群的最佳策略
  • 批准号:
    10447527
  • 财政年份:
    2022
  • 资助金额:
    $ 6.61万
  • 项目类别:
SARS-COV-2 Screening in Dialysis Facilities: Building an Optimal Strategy to Protect High Risk Populations
透析设施中的 SARS-COV-2 筛查:制定保护高危人群的最佳策略
  • 批准号:
    10549372
  • 财政年份:
    2022
  • 资助金额:
    $ 6.61万
  • 项目类别:
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney disease
病因不明的慢性肾病:应用多学科方法研究世界上最常见的肾小管间质性肾病
  • 批准号:
    10561691
  • 财政年份:
    2021
  • 资助金额:
    $ 6.61万
  • 项目类别:
Epidemiology and management of chronic kidney disease in South Asians
南亚人慢性肾脏病的流行病学和治疗
  • 批准号:
    8916107
  • 财政年份:
    2014
  • 资助金额:
    $ 6.61万
  • 项目类别:
Epidemiology and management of chronic kidney disease in South Asians
南亚人慢性肾脏病的流行病学和治疗
  • 批准号:
    8679738
  • 财政年份:
    2014
  • 资助金额:
    $ 6.61万
  • 项目类别:
Self reproted physical activity in the dialysis population
透析人群的自我报告体力活动
  • 批准号:
    8044170
  • 财政年份:
    2009
  • 资助金额:
    $ 6.61万
  • 项目类别:

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
  • 批准号:
    MR/Y009681/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.61万
  • 项目类别:
    Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
  • 批准号:
    MR/Y022947/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.61万
  • 项目类别:
    Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
  • 批准号:
    10068495
  • 财政年份:
    2024
  • 资助金额:
    $ 6.61万
  • 项目类别:
    Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    $ 6.61万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
  • 批准号:
    24K19850
  • 财政年份:
    2024
  • 资助金额:
    $ 6.61万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
  • 批准号:
    491810
  • 财政年份:
    2023
  • 资助金额:
    $ 6.61万
  • 项目类别:
    Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
  • 批准号:
    489316
  • 财政年份:
    2023
  • 资助金额:
    $ 6.61万
  • 项目类别:
    Operating Grants
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
  • 批准号:
    EP/Y027760/1
  • 财政年份:
    2023
  • 资助金额:
    $ 6.61万
  • 项目类别:
    Fellowship
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
  • 批准号:
    23K14987
  • 财政年份:
    2023
  • 资助金额:
    $ 6.61万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
  • 批准号:
    10696749
  • 财政年份:
    2023
  • 资助金额:
    $ 6.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了